NEW YORK, Sept. 10, 2025 /PRNewswire/ — ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced the appointment of Dr. Rochelle Walensky to its board of directors. The company is currently conducting a Phase…
